Structural Formula (Doxazosin Mesylate 4mg Tab For Mylan 1)
Doxazosin
Product Images NDC 33261-658
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 33261-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Table 1 (Doxazosin Mesylate 4mg Tab For Mylan 2)
This is a medical report about the maximum flow rate and symptom score of patients with hypertensives and BPH (Benign Prostatic Hyperplasia) receiving 8 mg dose of Doxazosin or placebo. The data is presented from three studies with different titration and dose periods, showing the mean baseline change and efficacy of the medication. The range of symptom scores and change being monitored is also specified. There were 236 patients that received the medication in the study.*
Figure 1 (Doxazosin Mesylate 4mg Tab For Mylan 3)
Image Label (Doxazosin Mesylate 4mg Tab For Mylan 4)
This is a medication called Doxazosin, which is a generic form of a drug called Cardura. The pills contain 4mg of the active ingredient Doxazosin Mesylate. They are distributed by AIDAREX PHARMACEUTICALS LLC. The pills are white, round, with a D11 imprinted on one side and a score on the other. The recommended dosage is to take them every few hours, as directed by a doctor. The medication is manufactured by Alphapharm Pty Ltd. in Australia.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
